Jay Miller
40

Jay Miller

Minnetonka med-tech firm brings scanning into operating room

Jay D. Miller looked down over the copper-sheathed surgical suites being built at IMRIS Inc.’s Minnetonka headquarters and dared to dream. He dreams of a day when his company’s technology that allows surgeons to take detailed MRIs and CT scans of patients during surgery will be in many more ...

Former Vital Images CEO Jay Miller named top exec at Imris Minneapolis / St. Paul Business Journal

Med-tech firm Imris, which recently relocated its headquarters from Canada to Minnetonka, has named Jay Miller its CEO effective Aug. 1. Miller joined Imris last year as the company's president and chief operating officer. He was previously CEO at Zonare and served as ...

IMRIS Inc (IMRS): IMRIS' CEO Discusses Q3 2013 Results

With me on our call today is Jay Miller, President and Chief Executive Officer. Please note that the comments made in today’s call may contain forward-looking information. These statements should not be understood as guarantees of future performance or results. Such statements involve ...

Paitents settle stent claims against Midei, St. Joseph

Paitents settle stent claims against Midei, St. Joseph - baltimoresun.com Paitents settle stent claims against Midei, St. Joseph - baltimoresun.com Paitents settle stent claims against Midei, St. Joseph Nearly 250 of the patients who accused cardiologist Dr. Mark Midei of performing unnecessary ...

IMRIS Reports Third Quarter 2012 Financial Results

Jay D. Miller Joins IMRIS as President and COO -- On September 7, 2012 IMRIS announced the appointment of Jay Miller as President and COO of the Company. Mr. Miller has extensive technical and managerial experience in the medical device industry. Prior to joining IMRIS he was the ...

IMRIS launches world's first MR-safe and CT-compatible neurosurgical horseshoe headrest

MINNEAPOLIS, Feb. 19, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS ; TSX: IM) ("IMRIS" or the "Company") today announced the initial launch of the world's first MR-safe and CT-compatible horseshoe headrest on the market for the positioning of patients ranging from neonatal to adult during ...

Nearly 13,000 patients have benefited from IMRIS VISIUS iMRI

MINNEAPOLIS, Jan. 8, 2014 /PRNewswire/ - IMRIS Inc. ( IMRS ) ( IM.TO ) ("IMRIS" or the "Company") today announced that an internal study of 40 worldwide VISIUS® Surgical Theatre hospital customers indicates that nearly 13,000 patients have been treated using intraoperative MRI (iMRI) since the ...

IMRIS to present at Investor Healthcare Conferences in New York

WINNIPEG TSX: IM), a leader in providing multi-functional intraoperative imaging environments, today announced that Jay D. Miller, the Company's President & Chief Executive Officer, will present a Corporate overview at ...

IMRIS Reports Third Quarter 2013 Financial Results

IMRIS Reports Third Quarter 2013 Financial Results - Yahoo Finance Mon, Nov 4, 2013, 4:09 PM EST - U.S. Markets closed Quarterly revenues were $17.8 million, an increase of 54 percent over the prior year; Net loss in the third quarter improved to $3.8 million, or $0.07 per diluted share...

IMRIS reports second quarter 2013 financial results

IMRIS reports second quarter 2013 financial results - Yahoo! Finance IMRIS reports second quarter 2013 financial results - Yahoo! Finance Tue, Aug 13, 2013, 5:38 PM EDT - U.S. Markets closed Quarterly revenues of $10.2 million were in line with expectations; Received FDA 510K clearance in the ...

Neurosurgery journal published study reinforces value of high-field iMRI

MINNEAPOLIS, April 17, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS ; TSX: IM) ("IMRIS" or the "Company") today announced that a study published this month in the journal Neurosurgery by the neurosurgical team at Cleveland Clinic adds to growing clinical evidence which validates use of ...

IMRIS sponsoring Practical Clinic and exhibiting intraoperative MR and CT imaging techniques at AAN...

MINNEAPOLIS, April 1, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS ; TSX: IM) ("IMRIS" or the "Company") today announced sponsorship of a Practical Clinic on brain mapping and awake surgical mapping techniques and exhibition at the American Association of Neurological Surgeons (AANS) 2014 ...

IMRIS pediatric horseshoe headrest enables iMRI for even the youngest neurosurgery patients

MINNEAPOLIS, March 26, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS ) (TSX: IM) ("IMRIS" or the "Company") today announced the initial uses of its neurosurgical horseshoe headrest with VISIUS® intraoperative MRI (iMRI) during two cases at Le Bonheur Children's Hospital in Memphis, TN. The IMRIS ...

Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial...

Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial brain tumor procedures... -- MINNEAPOLIS, March 19, 2014 Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial brain tumor procedures... -- ...

IMRIS reports 2013 fourth quarter and full-year financial results

2 Adjusted EBITDA is defined as earnings before interest income (expense) and other, stock based compensation, gain on asset sale, foreign exchange, embedded derivatives, income taxes and amortization and depreciation. WINNIPEG and MINNEAPOLIS, March 4, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: ...

IMRIS to hold fourth quarter and annual 2013 financial results conference call

WINNIPEG TSX: IM) Jay D. Miller, President and Chief Executive Officer; A question and answer session for analysts and institutional investors will follow management's presentation. A taped rebroadcast will be available to ...

IMRIS receives Australian regulatory clearance for intraoperative CT solution

MINNEAPOLIS, MN, Feb. 26, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that it has obtained Therapeutic Goods Administration (TGA) regulatory listing for VISIUS® iCT, the first and only ceiling-mounted intraoperative computed tomography...

IMRIS receives FDA clearance for next generation VISIUS Surgical Theatre

MINNEAPOLIS, Feb. 13, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS ; TSX: IM) ("IMRIS" or the "Company") today announced US Food and Drug Administration clearance of the newest generation VISIUS® Surgical Theatre which integrates Siemens' latest high-field MR scanners. The new core imaging ...

IMRIS receives Innovation in Medical Devices Award by MN Business Magazine

MINNEAPOLIS, Oct. 30, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS ; TSX: IM) ("IMRIS" or the "Company") announced that the company has received the 2013 Innovation in Medical Devices Award from Minnesota Business Magazine in recognition for significantly improving medical technology with the ...

IMRIS to hold third quarter 2013 results conference call WINNIPEG & MINNEAPOLIS, Oct. 28, 2013

WINNIPEG TSX: IM) Jay Miller, President and Chief Executive Officer; A question and answer session for analysts and institutional investors will follow management's presentation. A taped rebroadcast will be available ...

Join Newsle to find out when Jay Miller makes the news.

As a Newsle member, you’ll be able to:

  • Get alerts on Jay Miller
  • See news articles & blog posts about Jay Miller
  • Follow your friends & colleagues in the news
This profile only includes publicly available information. Questions or comments? Contact Us
Freebase CC-BY
Data from Freebase, licensed under CC-BY
Source: CrunchBase
Data from Wikipedia, licensed under the GFDL